[1]
“CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS”, MAJMHS, vol. 1, no. 8, pp. 51–63, Nov. 2025, Accessed: Jan. 30, 2026. [Online]. Available: https://usajournals.org/index.php/1/article/view/1362